1. Home
  2. news
  3. Health

Rise Therapeutics Secures New Funding to Advance First-in-Class R-2487 Oral Immune Biomodulator into Sjogren's Disease Clinical Testing

5 months ago | By: PR Newswire
Rise Therapeutics Secures New Funding to Advance First-in-Class R-2487 Oral Immune Biomodulator into Sjogren's Disease Clinical Testing
description

Supported by recent clinical data from the first-ever clinical study of an oral dendritic cell (DC) modulator in rheumatoid arthritis (RA), Rise Therapeutics is expanding into a second autoimmune indication, Sjögren's Disease (SjD) ROCKVILLE, Md., Se... [2607 chars].. reed more

(16)preview (15)click

Post your Blog Click here

Category

General

World

Nation

Business

Technology

Entertainment

Sports

Science

Health

Recent news
Power the AI-first retail revolution with Lenovo's Solutions & Services Group

Power the AI-first retail revolution with Lenovo's Solutions & Services Group

13 hours ago
Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

13 hours ago
OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

13 hours ago
Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

13 hours ago
Severe flooding kills 66 in Kenya, as heavy rains continue

Severe flooding kills 66 in Kenya, as heavy rains continue

13 hours ago
Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

13 hours ago